These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3332574)

  • 61. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
    Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
    Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S; Serradimigni A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses.
    Toal CB; Meredith PA; Elliott HL
    Int J Clin Pharmacol Ther; 2012 Mar; 50(3):202-17. PubMed ID: 22373833
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
    Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
    J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group.
    Tuck ML; Bravo EL; Krakoff LR; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):333S-341S. PubMed ID: 2078320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
    Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.
    Greminger P; Suter PM; Holm D; Kobelt R; Vetter W
    Clin Investig; 1994 Nov; 72(11):864-9. PubMed ID: 7894213
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system.
    Bittar N
    Am J Cardiol; 1989 Sep; 64(11):31F-34F. PubMed ID: 2675587
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)].
    Grzeszczak W
    Przegl Lek; 2000; 57(11):643-54. PubMed ID: 11293213
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
    Mancia G; Brown M; Castaigne A; de Leeuw P; Palmer CR; Rosenthal T; Wagener G; Ruilope LM;
    Hypertension; 2003 Mar; 41(3):431-6. PubMed ID: 12623939
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Slow-release nifedipine as a single or additional agent in the treatment of essential hypertension--a placebo-controlled crossover study.
    Wing LM; Chalmers JP; West MJ; Bune AJ
    Clin Exp Hypertens A; 1985; 7(8):1173-85. PubMed ID: 4042390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetic profile of nifedipine GITS in hypertensive patients with chronic renal impairment.
    Schneider R; Stolero D; Griffel L; Kobelt R; Brendel E; Iaina A
    Drugs; 1994; 48 Suppl 1():16-21; discussion 21-2. PubMed ID: 7533702
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative dosing and efficacy of continuous-release nifedipine versus standard nifedipine for angina pectoris: clinical response, exercise performance, and plasma nifedipine levels.
    Vetrovec GW; Parker VE; Alpert DA
    Am Heart J; 1988 Apr; 115(4):793-8. PubMed ID: 3354408
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
    Carter BL; Gersema LM; Williams GO; Schabold K
    Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension.
    Cappuccio FP; Markandu ND; Sagnella GA; Singer DR; Miller MA; Buckley MG; MacGregor GA
    Am J Med; 1991 Sep; 91(3):233-8. PubMed ID: 1832516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.